Lifeward — manufacturer of the ReWalk — has partnered with Ottobock Care in a six-month pilot program designed to “enable greater patient access to the ReWalk 7 personal exoskeleton.” In an Aug. 5 announcement, Lifeward said it will work with Ottobock Care’s nationwide network of orthopaedic care clinics “to increase awareness of ReWalk 7 among…
Ottobock Care, Lifeward Partner on ReWalk Outreach
Review: Webinar Compares Brain-Computer Interface Technologies, Predicts Timelines for Success
BCI technology could be used to control wheelchairs, exoskeletons and prosthetics.
Brain-computer interface (BCI) technology is already turning science-fiction concepts into everyday realities. But there are many different “mind control” approaches, with different goals and applications, and differing levels of invasiveness for the components that interact with the user’s brain. IDTechEx, an independent research firm focusing on emerging tech and related markets, took a deeper dive…
Commentary: Once Again, Wheelchairs Considered Second-Class Solutions
Medicare is now funding personal exoskeletons. But what’s so wrong about rolling?
In April, the Centers for Medicare & Medicaid Services (CMS) announced Medicare coverage for personal exoskeletons. ReWalk (DBA: Lifeward), an exoskeleton manufacturer, praised the decision: “The Centers for Medicare & Medicaid Services has officially revised its April 2024 Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) fee schedule to include a final lump-sum Medicare purchase…